Looking into the crystal ball: The 60‐5 criterion—a newly proposed predictor of severe complications after liver transplantation
Jay A. Graham, James V. Guarrera – 4 December 2013
Type I and type III interferon‐induced immune response: It's a matter of kinetics and magnitude
David Olagnier, John Hiscott – 4 December 2013
The times they are a‐changin'
Nedim Hadžić, Roshni Vara – 29 November 2013
Re‐evaluation of the predictive score for 6‐month graft survival in living donor liver transplantation in the modern era
Tomoharu Yoshizumi, Toru Ikegami, Yuki Bekki, Mizuki Ninomiya, Hideaki Uchiyama, Tomohiro Iguchi, Yo‐Ichi Yamashita, Hirofumi Kawanaka, Ken Shirabe, Yoshihiko Maehara – 29 November 2013 – The limitations of donor age, graft size, and the Model for End‐Stage Liver Disease (MELD) score have not been apparent in living donor liver transplantation (LDLT). Our team developed a formula for predicting graft survival after LDLT; the formula includes the graft weight, donor age, MELD score, and portosystemic shunt status.
Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan
Seisuke Sakamoto, Mureo Kasahara, Koichi Mizuta, Tatsuo Kuroda, Takahito Yagi, Tomoaki Taguchi, Yukihiro Inomata, Koji Umeshita, Shinji Uemoto, for the Japanese Liver Transplantation Society – 29 November 2013 – Recently, liver transplantation (LT) has been increasingly performed for unresectable hepatoblastoma (HB) with acceptable results. We conducted a national survey of cases undergoing living donor liver transplantation (LDLT) for HB to evaluate their outcomes.
Racial and economic disparities in transplant outcomes: The not‐so‐hidden morbidities
Eyal Shemesh, Lawrence C. Kleinman, Elizabeth A. Howell, Rachel Annunziato – 29 November 2013
Reply
Natasha T. Snider, M. Bishr Omary – 28 November 2013
Hepatocyte levels of CD73 contribute to Mallory‐Denk body formation
Samuel French – 28 November 2013
EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR‐dependent stabilization of MDM4 in hepatocellular carcinoma
Rossella Pellegrino, Diego F. Calvisi, Olaf Neumann, Venkatesh Kolluru, Josephine Wesely, Xin Chen, Chunmei Wang, Torsten Wuestefeld, Sara Ladu, Nahla Elgohary, Justo Lorenzo Bermejo, Bernhard Radlwimmer, Martin Zörnig, Lars Zender, Frank Dombrowski, Matthias Evert, Peter Schirmacher, Thomas Longerich – 28 November 2013 – Mouse Double Minute homolog 4 (MDM4) gene up‐regulation often occurs in human hepatocellular carcinoma (HCC), but the molecular mechanisms responsible for its induction remain poorly understood.